Global Dextrose Injection Market Size, Industry Analysis By Segmentations, Top Key Players, Trends, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 3/1/2023
- NO OF PAGES
- 286
- CATEGORY
- Healthcare & Life Sciences
Overview
The global dextrose injection market is expected to grow significantly in the coming years. Dextrose injection, also known as glucose injection, is a type of solution that is used to replenish the body's fluids and provide energy to the body. It is commonly used in hospitals and clinics to treat dehydration, hypoglycemia, and other conditions.
The increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases is one of the key drivers of the dextrose injection market. These diseases often require hospitalization and treatment with dextrose injection, which is expected to increase demand for the product.
In addition, the rising geriatric population, increasing number of surgeries and trauma cases, and growing demand for parenteral nutrition are expected to further drive market growth. However, the market may face challenges due to the availability of alternatives such as lactated Ringer's solution, which may limit the adoption of dextrose injection.
North America is expected to dominate the dextrose injection market due to the high prevalence of chronic diseases and a well-established healthcare system. The Asia Pacific region is also expected to grow significantly due to the increasing population and rising healthcare expenditure.
Key players in the dextrose injection market include B. Braun Melsungen AG, Fresenius Kabi AG, Hospira, Inc., Pfizer Inc., and Baxter International Inc. These companies are focusing on research and development to develop innovative products and expand their market presence.
Segment Overview
The dextrose injection market can be segmented based on various factors, including:
1. Type: Dextrose injection is available in various types, including 5% dextrose injection, 10% dextrose injection, and 50% dextrose injection.
2. Application: Dextrose injection is used for various applications, including fluid and electrolyte replenishment, as an energy source, and as a diluent for other medications.
3. End User: Dextrose injection is used in various settings, including hospitals, clinics, ambulatory surgical centers, and homecare settings.
4. Region: The dextrose injection market can be segmented based on geographic regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
5. Distribution Channel: The dextrose injection market can be segmented based on the distribution channel, including hospital pharmacies, retail pharmacies, and online pharmacies.
These are some of the common ways to segment the Dextrose Injection market, but there may be other ways depending on the specific needs and requirements of the market.
Geographical Overview
The dextrose injection market is a global market, with products available and distributed across various regions worldwide. North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the major regions where the market is distributed.
North America and Europe are the largest markets for dextrose injections due to the high prevalence of diabetes and obesity in these regions. The presence of major market players and increasing demand for parenteral nutrition products in hospitals and other healthcare settings also contribute to the growth of the market in these regions.
The Asia Pacific region is expected to experience the highest growth rate during the forecast period, due to the increasing prevalence of diabetes and obesity, rising healthcare expenditure, and the growing demand for parenteral nutrition products. Additionally, the increasing availability of dextrose injection products in hospitals and other healthcare settings in the region is expected to drive market growth.
Latin America and the Middle East and Africa are also expected to contribute to market growth, with rising awareness about the benefits of dextrose injections for patients with diabetes and other medical conditions. However, the market in these regions is relatively small compared to other regions due to the low availability of healthcare infrastructure and limited access to healthcare services.
Overall, the dextrose injection market is expected to continue growing in the coming years, driven by increasing demand for parenteral nutrition products, rising prevalence of diabetes and obesity, and growing healthcare expenditure worldwide.
COVID Impact
The COVID-19 pandemic has had a significant impact on the global healthcare industry, including the dextrose injection market. Dextrose injection is a type of intravenous solution used to treat dehydration and low blood sugar levels in patients. During the pandemic, the demand for dextrose injection increased due to the need for intravenous fluids in the treatment of COVID-19 patients.
One of the main impacts of COVID-19 on the dextrose injection market was the disruption of supply chains and logistics. The pandemic led to the closure of borders and restrictions on movement, which affected the transportation of goods and raw materials needed for the production of dextrose injection. This resulted in shortages of the product in some regions, leading to price increases and limited access to healthcare for some patients.
In addition, the pandemic also led to a surge in demand for dextrose injection in the healthcare industry. COVID-19 patients required intravenous fluids to manage dehydration and maintain electrolyte balance, which led to an increase in demand for dextrose injection. As a result, some manufacturers ramped up their production to meet the demand, while others faced challenges in sourcing raw materials and maintaining production levels.
Furthermore, the COVID-19 pandemic also led to changes in healthcare policies and practices that affected the use of dextrose injection. With the focus on managing the pandemic, some healthcare facilities postponed non-essential procedures and treatments, which reduced the demand for dextrose injection in certain regions. On the other hand, some healthcare facilities had to rapidly scale up their operations to accommodate the surge in demand for COVID-19 treatments, which led to increased use of dextrose injection.
Overall, the COVID-19 pandemic had a mixed impact on the dextrose injection market, with both positive and negative effects.
Competitive Analysis
Dextrose injection is a sterile, non-pyrogenic solution used for intravenous administration as a fluid and nutrient replenisher. It is a type of glucose solution that provides energy to the body and is used in various medical applications, such as in the treatment of dehydration, hypoglycemia, and insulin shock.
The dextrose injection market is highly competitive, with many companies manufacturing and distributing this product. Some of the major players in the market include Baxter International Inc., Hospira Inc., B. Braun Melsungen AG, and Fresenius Kabi AG. These companies have a significant market share and are continuously expanding their product portfolios through product launches, acquisitions, and collaborations.
In addition to the major players, there are also several smaller companies operating in the market. These companies are typically focused on a specific region or niche market and often offer lower-priced products than the larger players.
The market is also affected by regulatory factors and the availability of raw materials. Government regulations and quality standards are a significant barrier to entry for new players in the market, as compliance with these regulations can be expensive and time-consuming. The availability and cost of raw materials, such as glucose, also play a significant role in the market.
Overall, the dextrose injection market is highly competitive, with a few major players dominating the market. However, there are also opportunities for smaller companies to compete by focusing on niche markets or offering lower-priced products.
Key Benefits:
• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Dextrose Injection market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Dextrose Injection would help in identifying future applications in this market.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Objectives of the Study:
• To provide with an exhaustive analysis on the Dextrose Injection Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Historic Year: 2016-2022
Forecast: 2024-2035
1.1 Product Overview and Scope of Dextrose Injection
1.2 Classification of Dextrose Injection by Type
1.2.1 Overview: Global Dextrose Injection Market Size by Type: 2017 Versus 2022 Versus 2032
1.2.2 Global Dextrose Injection Revenue Market Share by Type in 2022
1.2.3 5% Dextrose Injection
1.2.4 10% Dextrose Injection
1.2.5 50% Dextrose Injection
1.2.6 70% Dextrose Injection
1.3 Global Dextrose Injection Market by Application
1.3.1 Overview: Global Dextrose Injection Market Size by Application: 2017 Versus 2022 Versus 2032
1.3.2 First-Aid Treatment
1.3.3 Sports
1.3.4 Trophotherapy
1.3.5 Others
1.4 Global Dextrose Injection Market Size & Forecast
1.5 Global Dextrose Injection Market Size and Forecast by Region
1.5.1 Global Dextrose Injection Market Size by Region: 2017 VS 2022 VS 2032
1.5.2 Global Dextrose Injection Market Size by Region, (2016-2021)
1.5.3 North America Dextrose Injection Market Size and Prospect (2017-2032)
1.5.4 Europe Dextrose Injection Market Size and Prospect (2017-2032)
1.5.5 Asia-Pacific Dextrose Injection Market Size and Prospect (2017-2032)
1.5.6 South America Dextrose Injection Market Size and Prospect (2017-2032)
1.5.7 Middle East and Africa Dextrose Injection Market Size and Prospect (2017-2032)
1.6 Market Drivers, Restraints and Trends
1.6.1 Dextrose Injection Market Drivers
1.6.2 Dextrose Injection Market Restraints
1.6.3 Dextrose Injection Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Dextrose Injection Product and Solutions
2.1.4 Pfizer Dextrose Injection Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Amphastar
2.2.1 Amphastar Details
2.2.2 Amphastar Major Business
2.2.3 Amphastar Dextrose Injection Product and Solutions
2.2.4 Amphastar Dextrose Injection Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 Amphastar Recent Developments and Future Plans
2.3 ChanGee
2.3.1 ChanGee Details
2.3.2 ChanGee Major Business
2.3.3 ChanGee Dextrose Injection Product and Solutions
2.3.4 ChanGee Dextrose Injection Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 ChanGee Recent Developments and Future Plans
2.4 Seqirus
2.4.1 Seqirus Details
2.4.2 Seqirus Major Business
2.4.3 Seqirus Dextrose Injection Product and Solutions
2.4.4 Seqirus Dextrose Injection Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 Seqirus Recent Developments and Future Plans
2.5 Baxter
2.5.1 Baxter Details
2.5.2 Baxter Major Business
2.5.3 Baxter Dextrose Injection Product and Solutions
2.5.4 Baxter Dextrose Injection Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Baxter Recent Developments and Future Plans
2.6 Shandong Qidu Pharmaceutical
2.6.1 Shandong Qidu Pharmaceutical Details
2.6.2 Shandong Qidu Pharmaceutical Major Business
2.6.3 Shandong Qidu Pharmaceutical Dextrose Injection Product and Solutions
2.6.4 Shandong Qidu Pharmaceutical Dextrose Injection Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 Shandong Qidu Pharmaceutical Recent Developments and Future Plans
2.7 Sanctus Drugs & Pharmaceuticals
2.7.1 Sanctus Drugs & Pharmaceuticals Details
2.7.2 Sanctus Drugs & Pharmaceuticals Major Business
2.7.3 Sanctus Drugs & Pharmaceuticals Dextrose Injection Product and Solutions
2.7.4 Sanctus Drugs & Pharmaceuticals Dextrose Injection Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 Sanctus Drugs & Pharmaceuticals Recent Developments and Future Plans
2.8 Mountainside Medical
2.8.1 Mountainside Medical Details
2.8.2 Mountainside Medical Major Business
2.8.3 Mountainside Medical Dextrose Injection Product and Solutions
2.8.4 Mountainside Medical Dextrose Injection Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 Mountainside Medical Recent Developments and Future Plans
2.9 Hospira
2.9.1 Hospira Details
2.9.2 Hospira Major Business
2.9.3 Hospira Dextrose Injection Product and Solutions
2.9.4 Hospira Dextrose Injection Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Hospira Recent Developments and Future Plans
2.10 B Braun
2.10.1 B Braun Details
2.10.2 B Braun Major Business
2.10.3 B Braun Dextrose Injection Product and Solutions
2.10.4 B Braun Dextrose Injection Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 B Braun Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Dextrose Injection Revenue and Share by Players (2017-2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Dextrose Injection Players Market Share
3.2.2 Top 10 Dextrose Injection Players Market Share
3.2.3 Market Competition Trend
3.3 Dextrose Injection Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Dextrose Injection Revenue and Market Share by Type (2016-2021)
4.2 Global Dextrose Injection Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Dextrose Injection Revenue Market Share by Application (2016-2021)
5.2 Dextrose Injection Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Dextrose Injection Revenue by Type (2017-2032)
6.2 North America Dextrose Injection Revenue by Application (2017-2032)
6.3 North America Dextrose Injection Market Size by Country
6.3.1 North America Dextrose Injection Revenue by Country (2017-2032)
6.3.2 United States Dextrose Injection Market Size and Forecast (2017-2032)
6.3.3 Canada Dextrose Injection Market Size and Forecast (2017-2032)
6.3.4 Mexico Dextrose Injection Market Size and Forecast (2017-2032)
7 Europe by Country, by Type, and by Application
7.1 Europe Dextrose Injection Revenue by Type (2017-2032)
7.2 Europe Dextrose Injection Revenue by Application (2017-2032)
7.3 Europe Dextrose Injection Market Size by Country
7.3.1 Europe Dextrose Injection Revenue by Country (2017-2032)
7.3.2 Germany Dextrose Injection Market Size and Forecast (2017-2032)
7.3.3 France Dextrose Injection Market Size and Forecast (2017-2032)
7.3.4 United Kingdom Dextrose Injection Market Size and Forecast (2017-2032)
7.3.5 Russia Dextrose Injection Market Size and Forecast (2017-2032)
7.3.6 Italy Dextrose Injection Market Size and Forecast (2017-2032)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Dextrose Injection Revenue by Type (2017-2032)
8.2 Asia-Pacific Dextrose Injection Revenue by Application (2017-2032)
8.3 Asia-Pacific Dextrose Injection Market Size by Region
8.3.1 Asia-Pacific Dextrose Injection Revenue by Region (2017-2032)
8.3.2 China Dextrose Injection Market Size and Forecast (2017-2032)
8.3.3 Japan Dextrose Injection Market Size and Forecast (2017-2032)
8.3.4 South Korea Dextrose Injection Market Size and Forecast (2017-2032)
8.3.5 India Dextrose Injection Market Size and Forecast (2017-2032)
8.3.6 Southeast Asia Dextrose Injection Market Size and Forecast (2017-2032)
8.3.7 Australia Dextrose Injection Market Size and Forecast (2017-2032)
9 South America by Country, by Type, and by Application
9.1 South America Dextrose Injection Revenue by Type (2017-2032)
9.2 South America Dextrose Injection Revenue by Application (2017-2032)
9.3 South America Dextrose Injection Market Size by Country
9.3.1 South America Dextrose Injection Revenue by Country (2017-2032)
9.3.2 Brazil Dextrose Injection Market Size and Forecast (2017-2032)
9.3.3 Argentina Dextrose Injection Market Size and Forecast (2017-2032)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Dextrose Injection Revenue by Type (2017-2032)
10.2 Middle East & Africa Dextrose Injection Revenue by Application (2017-2032)
10.3 Middle East & Africa Dextrose Injection Market Size by Country
10.3.1 Middle East & Africa Dextrose Injection Revenue by Country (2017-2032)
10.3.2 Turkey Dextrose Injection Market Size and Forecast (2017-2032)
10.3.3 Saudi Arabia Dextrose Injection Market Size and Forecast (2017-2032)
10.3.4 UAE Dextrose Injection Market Size and Forecast (2017-2032)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI